These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2507690)

  • 61. Nitrosation by stimulated macrophages. Inhibitors, enhancers and substrates.
    Kosaka H; Wishnok JS; Miwa M; Leaf CD; Tannenbaum SR
    Carcinogenesis; 1989 Mar; 10(3):563-6. PubMed ID: 2494000
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study.
    Nanda KK; Tignor S; Clancy J; Marota MJ; Allain LR; D'Addio SM
    J Pharm Sci; 2021 Dec; 110(12):3773-3775. PubMed ID: 34400183
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relationship between ascorbic acid dose and N-nitrosoproline excretion in humans on controlled diets.
    Leaf CD; Vecchio AJ; Roe DA; Hotchkiss JH
    IARC Sci Publ; 1987; (84):299-303. PubMed ID: 3679390
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of vitamin E to prevent nitrosamine formation.
    Mergens WJ
    Ann N Y Acad Sci; 1982; 393():61-9. PubMed ID: 6959571
    [No Abstract]   [Full Text] [Related]  

  • 65. Consumption of precursors of N-nitroso compounds and human gastric cancer.
    Choi NW; Miller AB; Fodor JG; Jain M; Howe GR; Risch HA; Ruder AM
    IARC Sci Publ; 1987; (84):492-6. PubMed ID: 3679429
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pyrroles as effective agents for blocking amine nitrosation.
    Wilcox AL; Bao YT; Loeppky RN
    Chem Res Toxicol; 1991; 4(3):373-81. PubMed ID: 1912323
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Nitrosamine formation from vegetables produced in Japan].
    Ohtsuki R; Kikugawa K
    Shokuhin Eiseigaku Zasshi; 2005 Apr; 46(2):58-61. PubMed ID: 16018593
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ascorbic acid and the formation of N-nitroso compounds: possible role of ascorbic acid in cancer prevention.
    Kyrtopoulos SA
    Am J Clin Nutr; 1987 May; 45(5 Suppl):1344-50. PubMed ID: 3578122
    [No Abstract]   [Full Text] [Related]  

  • 69. Modified NAP test: A simple and Responsive Nitrosating Methodology for Risk Evaluation of NDSRIs.
    Sharma N; Patel R; Bothara T; Jain S; Shah RP
    J Pharm Sci; 2023 May; 112(5):1333-1340. PubMed ID: 36871894
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of nitrosamine formation by ascorbic acid: participation of free radicals in its anaerobic reaction with nitrite.
    Kalus WH; Filby WG
    Experientia; 1980 Feb; 36(2):147-9. PubMed ID: 6245907
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Susceptibilities of drugs to nitrosation under simulated gastric conditions.
    Gillatt PN; Palmer RC; Smith PL; Walters CL; Reed PI
    Food Chem Toxicol; 1985 Sep; 23(9):849-55. PubMed ID: 4043885
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of ascorbic acid to inhibit nitrosation: kinetic and mass transfer considerations for an in vitro system.
    Licht WR; Tannenbaum SR; Deen WM
    Carcinogenesis; 1988 Mar; 9(3):365-72. PubMed ID: 3345578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acceleration of N-nitrosation reactions by electrophiles.
    Sullivan BP; Meyer TJ; Stershic MT; Keefer LK
    IARC Sci Publ; 1991; (105):370-4. PubMed ID: 1855883
    [TBL] [Abstract][Full Text] [Related]  

  • 74. N-nitrosamine Mitigation with Nitrite Scavengers in Oral Pharmaceutical Drug Products.
    Bayne AV; Misic Z; Stemmler RT; Wittner M; Frerichs M; Bird JK; Besheer A
    J Pharm Sci; 2023 Jul; 112(7):1794-1800. PubMed ID: 37023856
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effect of ascorbic acid on the amine-nitrite and nitrosamine mutagenicity in bacteria injected into mice.
    Neale S; Solt AK
    Chem Biol Interact; 1981 May; 35(2):199-205. PubMed ID: 7011582
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of soyabean and ascorbic acid on experimental carcinogenesis.
    Fitzsimons JT; Orson NV; el-Aaser AA
    Comp Biochem Physiol A Comp Physiol; 1989; 93(1):285-90. PubMed ID: 2568231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Formation of N-nitrosomorpholine in mice treated with morpholine and exposed to nitrogen dioxide.
    Norkus EP; Boyle S; Kuenzig W; Mergens WJ
    Carcinogenesis; 1984 May; 5(5):549-54. PubMed ID: 6722975
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Demonstration of in vivo formation of the nitrosamine N-nitroso-N-methylaniline from amyl nitrite.
    Mirvish SS; Ramm MD
    Cancer Lett; 1987 Aug; 36(2):125-9. PubMed ID: 2887279
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets.
    Shakleya D; Asmelash B; Alayoubi A; Abrigo N; Mohammad A; Wang J; Zhang J; Yang J; Marzan TA; Li D; Shaklah M; Alsharif FM; Desai S; Faustino PJ; Ashraf M; O'Connor T; Vera M; Raw A; Sayeed VA; Keire D
    J Pharm Sci; 2023 Dec; 112(12):3075-3087. PubMed ID: 37364772
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The nitrosation of hexetidine and hexedine: characterization of the major nitrosamine from common antimicrobial agents.
    Bae JY; Mende P; Shevlin G; Spiegelhalder B; Preussmann R; Loeppky RN
    Chem Res Toxicol; 1994; 7(6):868-76. PubMed ID: 7696545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.